Basel, 29 October 2019 Roche and Spark Therapeutics, Inc. announce extension of tender offer for shares of Spark Therapeutics, Inc. Roche (SIX: RO, ROG; OTCQX: RHHBY) and Spark Therapeutics, Inc. (NASDAQ: ONCE) (“Spark”) today announced that Roche has extended the offering period of its previously announced tender offer to purchase all of the outstanding shares... Read more
ETTLINGEN, Germany, October 28, 2019 – Bruker today announced the launch of the novel, stand-alone FTIR (Fourier Transform Infrared) imaging microscope LUMOS II, which provides ultrafast FTIR imaging capabilities using focal-plane array (FPA) detectors in its high-end version. The new, automated LUMOS II is designed to identify particles, to determine coatings and contaminations, and to... Read more
Thermo Fisher Scientific Launches New External Molecular Control Panel for the Analytical Evaluation of BCR-ABL Test Methods FREMONT, Calif., Oct. 17, 2019 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, today announced the availability of the Thermo Scientific Acrometrix BCR-ABL Panel, its latest molecular quality control panel. The Acrometrix BCR-ABL Panel is... Read more
CHICAGO, IL and CHARLOTTE, N.C. (October 16, 2019) – GE Healthcare and Premier Inc. (NASDAQ: PINC) announced a collaboration to develop a model to bring a same-day breast cancer diagnosis and treatment model to the United States. A similar model has already proven effective at the Gustave Roussy Cancer Campus in France. Launched in 2004,... Read more
Oct 29, 2019 FRANKLIN LAKES, N.J., and WAGENINGEN, THE NETHERLANDS, October 29, 2019 – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, along with Check-Points Health B.V., announced today that FDA 510(k) clearance was obtained for a molecular screening test for antibiotic-resistant carbapenemase-producing organisms (CPOs) on the fully-automated BD MAX™ System. The BD MAX™ Check-Points... Read more
New kit shown to achieve over 90% correlation rate between biopsied embryos and testing spent culture media WALTHAM, Mass. – October 14, 2019 – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today introduced its PG-Seq™ Rapid Non-Invasive Preimplantation Genetic Testing for Aneuploidy (PGT-A) kit. This solution tests spent embryo culture... Read more
MilliporeSigma today announced it has acquired FloDesign Sonics, of Wilbraham, Massachusetts, developer of a unique acoustic cell processing platform 10 OCT 2019 | BURLINGTON, MASSACHUSETTS, UNITED STATES OF AMERICA Acquisition of FloDesign Sonics marks next step in autologous manufacturing MilliporeSigma today announced it has acquired FloDesign Sonics, of Wilbraham, Massachusetts, developer of a unique acoustic cell processing platform for... Read more
230 medical imaging units will be replaced and updated within first four years Equipment will support the public health system’s goal of standardizing care and providing patients modernized, state-of-the-art imaging technology New York, NY – October 10, 2019 –NYC Health + Hospitals today announced that it is investing $224 million over ten-years to upgrade medical imaging technology... Read more
Theragnostics’ novel PET tracer, GalliProst, will help visualize prostate cancer to enable personalized treatment. The two companies will leverage their combined scientific, commercial and market access expertise to work towards a commercial launch. Chalfont St Giles, UK – October 9th 2019 – GE Healthcare and Theragnostics have entered into a global commercial partnership for a... Read more
San Diego, California, Hilden, Germany and Germantown, Maryland – October 7, 2019 – Illumina, Inc. (NASDAQ: ILMN) and QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a 15-year partnership intended to broaden the availability and use of NGS-based in-vitro diagnostic (IVD) kits, including companion diagnostics, for patient management. The agreement grants QIAGEN non-exclusive... Read more